LIDOCAINE 2% / MUPIROCIN 2%- lidocaine 2% / mupirocin 2% ointment 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

LIDOCAINE 2% / MUPIROCIN 2%

Directions for use

d

Sincerus Florida, LLC. Adverse reactions

s

Active, inactive

d

NDC 72934- 5139-2 LIDOCAINE 2% / MUPIROCIN 2%. Ointment 30gm.

z

LIDOCAINE 2% / MUPIROCIN 2% 
lidocaine 2% / mupirocin 2% ointment
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-5139
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MUPIROCIN (UNII: D0GX863OA5) (MUPIROCIN - UNII:D0GX863OA5) MUPIROCIN2 g  in 100 g
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE2 g  in 100 g
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-5139-230 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product05/15/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/15/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Florida, LLC080105003manufacture(72934-5139)

Revised: 5/2019
Document Id: 88de6337-6871-7248-e053-2a95a90ae412
Set id: 88de6337-6870-7248-e053-2a95a90ae412
Version: 1
Effective Time: 20190514
 
Sincerus Florida, LLC